Literature DB >> 3372509

Rabbit liver growth hormone receptor and serum binding protein. Purification, characterization, and sequence.

S A Spencer1, R G Hammonds, W J Henzel, H Rodriguez, M J Waters, W I Wood.   

Abstract

A putative growth hormone receptor from detergent-solubilized rabbit liver membranes and the growth hormone binding protein from rabbit serum have been purified 59,000- and 400,000-fold, respectively, primarily by affinity chromatography. Both purified proteins exhibit high affinity binding for human growth hormone; K alpha = 9-30 x 10(9) M-1 for the liver receptor and K alpha = 6 x 10(9) M-1 for the binding protein. The apparent molecular weight of the liver receptor is 130,000 by reduced sodium dodecyl sulfate gel electrophoresis, while that of the binding protein is 51,000. Both contain N-linked carbohydrate. The amino-terminal sequences of the liver growth hormone receptor and the serum binding protein were found to be the same, indicating that the binding protein corresponds to the extracellular domain of the liver receptor. Ubiquitin was found covalently linked to the liver receptor but not to the serum binding protein. The amino acid sequences of several peptides from the liver receptor were also determined after tryptic and V8 protease digestion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3372509

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor.

Authors:  S H Bass; M G Mulkerrin; J A Wells
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

2.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Monoclonal antibodies to the pituitary growth-hormone receptor by the anti-idiotypic approach. Production and initial characterization.

Authors:  M I Elbashir; T Brodin; B Akerström; J Donnér
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

4.  Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1.

Authors:  P M Handley; M Mueckler; N R Siegel; A Ciechanover; A L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

5.  Allosteric effects of monoclonal antibodies on human growth hormone.

Authors:  R C Aguilar; L A Retegui; M C Postel-Vinay; L P Roguin
Journal:  Mol Cell Biochem       Date:  1994-07-13       Impact factor: 3.396

6.  Growth hormone activates phospholipase C in proximal tubular basolateral membranes from canine kidney.

Authors:  S A Rogers; M R Hammerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

7.  Functional growth hormone (GH) receptors and GH are expressed by preimplantation mouse embryos: a role for GH in early embryogenesis?

Authors:  M Pantaleon; E J Whiteside; M B Harvey; R T Barnard; M J Waters; P L Kaye
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

8.  MAP dendrimer elicits antibodies for detecting rat and mouse GH-binding proteins.

Authors:  Roberto M Aguilar; Frank J Talamantes; Juan J Bustamante; Jesus Muñoz; Lisa R Treviño; Andrew O Martinez; Luis S Haro
Journal:  J Pept Sci       Date:  2009-02       Impact factor: 1.905

9.  Development of a bioassay system for human growth hormone determination with close correlation to immunoassay.

Authors:  M Maimaiti; Y Tanahashi; Z Mohri; K Fujieda
Journal:  J Clin Lab Anal       Date:  2012-09       Impact factor: 2.352

10.  Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications.

Authors:  J D Veldhuis; M L Johnson; L M Faunt; M Mercado; G Baumann
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.